Alemà, G. in Proceedings of the 5th World Congress of Psychiatry (eds de la Fuente, R. & Weisman, M. N.) 1221–1227 (American Elsevier, 1973).
Masters, C. L. et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann. Neurol. 5, 177–188 (1979).
Article CAS PubMed Google Scholar
Will, R. G. et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. Ann. Neurol. 43, 763–767 (1998).
Article CAS PubMed Google Scholar
Watson, N. et al. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat. Rev. Neurol. 17, 362–379 (2021).
Article PubMed PubMed Central Google Scholar
Watson, N. et al. Validation of revised International Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease. JAMA Netw. Open. 5, e2146319 (2022).
Article PubMed PubMed Central Google Scholar
Ladogana, A. et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64, 1586–1591 (2005). This study provides comparative data on disease mortality in Europe as a joint effort of national surveillance systems.
Article CAS PubMed Google Scholar
Ladogana, A. et al. Creutzfeldt-Jakob disease: the public health perception. Eur. J. Neurodeg Dis. 1, 101–113 (2012).
D’Aignaux, J. H. et al. Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. Int. J. Epidemiol. 31, 490–495 (2002).
Nakatani, E. et al. Temporal and regional variations in sporadic Creutzfeldt-Jakob disease in Japan, 2001-2010. Epidemiol. Infect. 143, 1073–1078 (2015).
Article CAS PubMed Google Scholar
Puopolo, M. et al. Spatial epidemiology of sporadic Creutzfeldt-Jakob disease in Apulia, Italy. Neuroepidemiology 54, 83–90 (2020).
Klug, G. M. et al. Intensity of human prion disease surveillance predicts observed disease incidence. J. Neurol. Neurosurg. Psychiatry 84, 1372–1377 (2013).
Sun, Y. et al. Incidence of and mortality due to human prion diseases in Taiwan: a prospective 20-year nationwide surveillance study from 1998 to 2017. Clin. Epidemiol. 12, 1073–1081 (2020).
Article PubMed PubMed Central Google Scholar
Stehmann, C. et al. Communicable Diseases Intelligence. Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2022. Commonwealth of Australia Department of Health and Aged Care https://doi.org/10.33321/cdi.2023.47.37 (2023).
Kim, Y. C. & Jeong, B. H. Creutzfeldt-Jakob disease incidence, South Korea, 2001-2019. Emerg. Infect. Dis. 28, 1863–1866 (2022).
Article PubMed PubMed Central Google Scholar
Government of Canada. Creutzfeldt-Jakob Disease Surveillance System (CJDSS) report. Government of Canada www.canada.ca/en/public-health/services/surveillance/blood-safety-contribution-program/creutzfeldt-jakob-disease/cjd-surveillance-system.html (2023).
Hermann, P. et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 20, 235–246 (2021). This paper summarizes the current knowledge on clinical biomarkers and consensus guidelines by experts from national CJD surveillance systems for clinical diagnosis.
Article CAS PubMed PubMed Central Google Scholar
Parchi, P. et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46, 224–233 (1999).
Article CAS PubMed Google Scholar
Denouel, A. et al. The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis. Eur. J. Epidemiol. 38, 757–764 (2023).
Article PubMed PubMed Central Google Scholar
Pocchiari, M. et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 127, 2348–2359 (2004).
Article CAS PubMed Google Scholar
Alperovitch, A. et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353, 1673–1674 (1999). This paper provides evidence for the role of the codon 129 genotype of the prion protein gene in disease susceptibility in sporadic CJD.
Article CAS PubMed Google Scholar
Palmer, M. S., Dryden, A. J., Hughes, J. T. & Collinge, J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352, 340–342 (1991).
Article ADS CAS PubMed Google Scholar
Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363–13383 (1998).
Article ADS CAS PubMed PubMed Central Google Scholar
Mead, S., Lloyd, S. & Collinge, J. Genetic factors in mammalian prion diseases. Annu. Rev. Genet. 53, 117–147 (2019).
Article CAS PubMed Google Scholar
Brown, P. et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35, 513–529 (1994).
Article CAS PubMed Google Scholar
Tateishi, J. et al. First experimental transmission of fatal familial insomnia. Nature 376, 434–435 (1995).
Article ADS CAS PubMed Google Scholar
Tateishi, J., Kitamoto, T., Hoque, M. Z. & Furukawa, H. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 46, 532–537 (1996).
Article CAS PubMed Google Scholar
Minikel, E. V. et al. Quantifying prion disease penetrance using large population control cohorts. Sci. Transl. Med. 8, 322ra329 (2016).
Kovacs, G. G. et al. Genetic prion disease: the EUROCJD experience. Hum. Genet. 118, 166–174 (2005).
Article CAS PubMed Google Scholar
Kim, D. Y., Shim, K. H., Bagyinszky, E. & An, S. S. A. Prion mutations in Republic of Republic of Korea, China, and Japan. Int. J. Mol. Sci. 24, 625 (2022).
Article PubMed PubMed Central Google Scholar
Ladogana, A. & Kovacs, G. G. Genetic Creutzfeldt-Jakob disease. Handb. Clin. Neurol. 153, 219–242 (2018).
Brown, P. et al. Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J. Neurol. Sci. 112, 65–67 (1992).
Article CAS PubMed Google Scholar
Duffy, P. et al. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N. Engl. J. Med. 290, 692–693 (1974).
Article CAS PubMed Google Scholar
Brown, P. et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg. Infect. Dis. 18, 901–907 (2012).
Article PubMed PubMed Central Google Scholar
Rudge, P. et al. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain 138, 3386–3399 (2015).
Article PubMed PubMed Central Google Scholar
National CJD. Surveillance Unit. Creutzfeldt-Jakob disease in the UK. NCJDRSU www.cjd.ed.ac.uk/sites/default/files/figs.pdf (2024).
Takumi, I. & Akino, K. Creutzfeldt-Jakob disease and lyodura:a special reference to prion disease control in the field of neurosurgery [Japanese]. No Shinkei Geka 50, 1078–1086 (2022).
Hamaguchi, T. et al. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J. Neurol. Neurosurg. Psychiatry 84, 1171–1175 (2013).
Kobayashi, Y., Kitamoto, T. & Mizusawa, H. Iatrogenic Creutzfeldt-Jakob disease. Handb. Clin. Neurol. 153, 207–218 (2018).
Brandel, J. P. et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362, 128–130 (2003).
Article CAS PubMed Google Scholar
Peckeu, L. et al. Factors influencing the incubation of an infectious form of Creutzfeldt-Jakob disease. Clin. Infect. Dis. 70, 1487–1490 (2020).
Will, R. G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921–925 (1996).
Article CAS PubMed Google Scholar
Diack, A. B. et al. Variant CJD. 18 years of research and surveillance. Prion 8, 286–295 (2014).
留言 (0)